ММВБ 2 572 1,0%  Nasdaq 7 373 -1,5%  Биткойн 6 812 -1,0%  USD/RUB 76,6030 0,2% 
РТС 1 050 1,5%  S&P500 2 489 -1,5%  Нефть 34,7 16,7%  EUR/RUB 82,7420 0,0% 
Dow 21 053 -1,7%  FTSE100 5 416 -1,2%  EUR/USD 1,0804 -0,1% 

Курс акций Clinuvel Pharmaceuticals [ISIN: AU000000CUV3]

купить
продать

Clinuvel Pharmaceuticals LtdShs - Профиль

Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.

Акционеры

Название Доля (%)
Freefloat78,51
Philippe J. Wolgen, MD, MBA7,09
FIL Investment Management (Hong Kong) Ltd.5,00
Lagoda Investment Management LP4,99
Ender 1 LLC4,78
Willem A. Blijdorp3,56
Mark Edwin Badcock2,54
Fidelity Funds Sicav - Pacific Fund1,98
Vanguard Total International Stock Index Fund1,29
Vanguard Australian Shares Index Fund0,83
Fidelity Funds Sicav - Asian Smaller Companies Fund0,68
Dennis J. Wright, PhD0,64
Darren M. Keamy, CPA0,63
Brenda Mary Shanahan0,53

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент